Complete 2012-13 Induced Pluripotent Stem Cell Industry Report
DUBLIN, March 25, 2013 /PRNewswire/ --
Research and Markets has announced the addition of the "Complete 2012-13 Induced Pluripotent Stem Cell Industry Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
Stem cell research and experimentation has been in process for well over five decades. Stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being unspecialized with the ability to differentiate into specialized cell types. The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain on the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community.
Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use.
Perhaps the most distinctive feature of this report are the breakthrough findings discovered as a result of surveying 293 researchers that identify as having induced pluripotent stem cells as their core research focus. Of the 293 respondents, 181 were U.S. based and 112 were international. These key survey findings reveal iPSC researcher wants and needs, technical preferences, and key factors influencing buying decisions. These vital findings can be used to direct the product development and product positioning decisions. Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.
Key Findings Include:
- Charts, Timelines, Metrics and Financials for the iPSC Research Product Market
- Trends for iPSC Grants, Publications, Patents, and More
- 5-Year Market Projection Data for 2012-2017
- Competitive Environment Analysis, Including Market Share by Competitor
- Preferred Species for iPSC Research
- iPSC Product Categories (Breakdown of Market Share by Each)
- Consumer Behavioral Patterns and Preferred Providers
- Crucial Trends and Unmet Market Needs
- "Tested Sentences" for Selling to iPSC Scientists
- Trends in Marketing, Including a Breakdown of the Marketing Methods Used by Your Competition - Google Ads, Facebook Ads, App Advertising, Purchased Email Lists, Website Advertisements, Trade Journals, and More.
- End-User Wants/Needs, Technical Preferences, and Factors Influencing Purchasing Decisions (Survey of iPSC Researchers)
In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage crucial iPSC trends. Claim this report now to profit from this expanding market- or your competition will.
For more information visit http://www.researchandmarkets.com/research/kjm8bn/complete_201213
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article